- Investing Ideas
- /
- German Pharmaceuticals & Biotech Potentially Undervalued Companies
German Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
420
0 new
Companies with a Value score of at least 3, ordered by Value score
420 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NTR | US$0.93 | 0.5% | 11.6% | US$209.9m | US$1.13 | PS8.2x | E67.3% | n/a | ||
PIG | US$23.96 | -8.3% | -24.2% | US$3.6b | US$33.76 | PB0.8x | E59.2% | 4.1% | ||
2IVB | UK£9.00 | -18.9% | -57.2% | UK£972.1m | UK£21.71 | PS1.1x | E49.1% | 0% | ||
LDZA | R9.75 | -5.3% | 22.6% | R85.6b | R12.16 | PE19.4x | E22.3% | 1.9% | ||
K67 | US$18.00 | -8.6% | -28.6% | US$1.8b | US$22.04 | PB1.2x | E73.9% | n/a | ||
APPH | €6.78 | -4.2% | 40.7% | €58.0m | €16.93 | PS1.4x | E77.1% | n/a | ||
6MK | US$104.00 | -0.2% | 2.8% | US$292.3b | US$125.37 | PE21.3x | E14.4% | 2.7% | ||
IDP | US$180.85 | -2.0% | -24.8% | US$29.2b | US$244.65 | PE25.2x | E17.0% | n/a | ||
PHGN | €0.66 | -1.9% | -45.1% | €446.4m | €1.79 | PS1.8x | E64.6% | n/a | ||
VV5 | CA$0.16 | 6.5% | -6.3% | CA$61.4m | n/a | PS1.4x | S43.7% | n/a | ||
EXK | US$52.92 | -4.6% | -28.4% | US$10.9b | US$68.72 | PS4.1x | E69.5% | n/a | ||
5EA | US$13.56 | 0.09% | 24.4% | US$7.2b | US$17.49 | PS1.6x | E71.9% | n/a | ||
2M7C | HK$0.78 | -6.6% | -40.8% | HK$16.8b | HK$1.22 | PE11x | E21.4% | 6.2% | ||
640 | HK$0.58 | -1.7% | 0% | HK$30.3b | n/a | PE7.3x | E7.8% | 3.5% | ||
IDP | US$180.50 | -2.6% | -24.7% | US$29.2b | US$244.18 | PE25.2x | E17.0% | n/a | ||
29A | US$39.79 | -5.6% | -7.0% | US$2.2b | US$53.64 | PE13x | E14.1% | n/a | ||
6MK | US$104.20 | 0.6% | 3.0% | US$292.3b | US$125.61 | PE21.3x | E14.4% | 2.7% | ||
6QC | JP¥18.40 | 1.7% | -1.1% | JP¥142.3b | JP¥22.88 | PE8.4x | E-4.2% | 2.1% | ||
APPH | €6.96 | -5.4% | 38.1% | €58.0m | €17.38 | PS1.4x | E77.1% | n/a | ||
A3DTP0 | US$0.085 | 0% | -83.0% | US$1.3m | n/a | PB0.2x | E2.9% | n/a | ||
MX6A | HK$0.48 | -0.8% | -0.8% | HK$15.2b | n/a | PE6.3x | E7.1% | 6.0% | ||
BRM | US$43.97 | -2.9% | -21.8% | US$98.3b | US$47.59 | PS2.1x | E49.0% | 4.9% | ||
HBI | US$2.36 | -7.1% | -37.9% | US$116.9m | US$5.16 | PS1.2x | E83.0% | n/a | ||
VIA | US$10.10 | -6.4% | 11.4% | US$13.3b | US$11.66 | PB0.7x | E14.4% | 4.3% |